Blaise Coleman
-
As Malvern’s Endo Emerges from Bankruptcy, It Focuses on Growing Branded Pharmaceuticals Segment
Endo Inc., formed as a result of Malvern-based Endo International’s bankruptcy reorganization plan, has finalized the acquisition of most of the assets of its predecessor,…
-
Court Approves Malvern-based Endo International’s Reorganization Plan to Wipe Its Debt
Malvern-based Endo International received court approval earlier this week for its reorganization plan, over 18 months after the company filed for Chapter 11 bankruptcy protection,…
-
Malvern’s Endo International Reaches Deal to Prepare to Emerge from Bankruptcy
Endo International, the Ireland-based biopharmaceutical company with U.S. headquarters in Malvern, is on track to finally emerge from bankruptcy after reaching a deal with the…
-
State Attorney Generals Object to Bonuses Paid to Malvern’s Endo Executives Before Bankruptcy
Seven state attorneys general, including Pennsylvania AG Josh Shapiro, and a federal bankruptcy overseer appointed by the court, are objecting to the $94 million paid…
-
As Malvern’s Endo Bankruptcy Saga Continues, $55.5 Million in Bonuses Sent to Executives Revealed
Endo International, with North American headquarters in Malvern, filed for bankruptcy last week, yet it has been revealed that $55.5 million in bonuses were paid…
-
Malvern’s Endo Plans to Restructure, Eliminate 560 Positions
Endo International, the Dublin-based pharmaceutical company with its U.S. headquarters in Malvern, has announced plans to restructure the company and eliminate 560 jobs across the…
-
Malvern’s Endo to Acquire Local Company for $658 Million and Bring Its Cellulite-Fighting Drug to Market
Malvern-based Endo Pharmaceuticals has agreed to acquire BioSpecifics Technologies, a 20-year-old company based in Wilmington, for around $658 million, writes Joseph DiStefano for The Philadelphia…
-
New Drug from Malvern’s Endo the First Injectable Treatment for Cellulite Cleared by the FDA
Endo International, the Dublin-based pharmaceutical company with its U.S. headquarters in Malvern, has received marketing approval from the FDA for its injectable drug to treat…
-
Malvern’s Endo Finds New CEO, a Former College Football All-American, from Within
Endo International, the Dublin-based pharmaceutical company that has its U.S. headquarters in Malvern, has found its new CEO in Blaise Coleman. He is currently the…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
